KOREA WHO
-
-
-
Chairman of the Board at Lunit
Baek Seung-wook
KAIST PhD Graduate Founds AI Startup to Conquer Cancer, Focuses on Future Strategies
-
Last Updated on Feb 13, 2025
-
Chairman of the Board at Lunit
Life Summary
Baek Seung-wook is the Chairman of the Board at Lunit. As a founder, he also serves as the Chief Innovation Officer (CIO).
He is focused on discovering future new businesses and fostering collaborations with the world's top five pharmaceutical companies.
He was born on July 20, 1983.
He graduated from the Korea Advanced Institute of Science and Technology (KAIST) with a degree in electronic engineering and earned both his master's and doctoral degrees from the same institution.
During his second year at KAIST, he assisted with research at a company founded by a senior student, which inspired his entrepreneurial ambitions. After graduation, in 2013, he co-founded a company named CLDI with fellow KAIST alumni. In 2015, the company changed its name to Lunit, and he became its CEO.
As a first-generation medical AI company, Lunit aims to conquer cancer through artificial intelligence.
Within ten years of its founding, he grew the company into a KRW 1 trillion (US$ 721.2 million) enterprise.
His goal is to establish an innovative AI-powered medical support system covering the entire cancer diagnosis and treatment process.
#BaekSeungwook #Lunit #AIHealthcare #MedicalAI #CancerDiagnosis #CancerTreatment #KAIST #Startup #Innovation #Biotech
He is focused on discovering future new businesses and fostering collaborations with the world's top five pharmaceutical companies.
He was born on July 20, 1983.
He graduated from the Korea Advanced Institute of Science and Technology (KAIST) with a degree in electronic engineering and earned both his master's and doctoral degrees from the same institution.
During his second year at KAIST, he assisted with research at a company founded by a senior student, which inspired his entrepreneurial ambitions. After graduation, in 2013, he co-founded a company named CLDI with fellow KAIST alumni. In 2015, the company changed its name to Lunit, and he became its CEO.
As a first-generation medical AI company, Lunit aims to conquer cancer through artificial intelligence.
Within ten years of its founding, he grew the company into a KRW 1 trillion (US$ 721.2 million) enterprise.
His goal is to establish an innovative AI-powered medical support system covering the entire cancer diagnosis and treatment process.
#BaekSeungwook #Lunit #AIHealthcare #MedicalAI #CancerDiagnosis #CancerTreatment #KAIST #Startup #Innovation #Biotech